94 related articles for article (PubMed ID: 29084736)
1. Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).
Yaghi S; Furie KL; Viscoli CM; Kamel H; Gorman M; Dearborn J; Young LH; Inzucchi SE; Lovejoy AM; Kasner SE; Conwit R; Kernan WN;
Circulation; 2018 Jan; 137(5):455-463. PubMed ID: 29084736
[TBL] [Abstract][Full Text] [Related]
2. Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone.
Young LH; Viscoli CM; Schwartz GG; Inzucchi SE; Curtis JP; Gorman MJ; Furie KL; Conwit R; Spatz ES; Lovejoy A; Abbott JD; Jacoby DL; Kolansky DM; Ling FS; Pfau SE; Kernan WN;
Circulation; 2018 Sep; 138(12):1210-1220. PubMed ID: 29934374
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus.
Young LH; Viscoli CM; Curtis JP; Inzucchi SE; Schwartz GG; Lovejoy AM; Furie KL; Gorman MJ; Conwit R; Abbott JD; Jacoby DL; Kolansky DM; Pfau SE; Ling FS; Kernan WN;
Circulation; 2017 May; 135(20):1882-1893. PubMed ID: 28246237
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial.
Viscoli CM; Brass LM; Carolei A; Conwit R; Ford GA; Furie KL; Gorman M; Guarino PD; Inzucchi SE; Lovejoy AM; Parsons MW; Peduzzi PN; Ringleb PA; Schwartz GG; Spence JD; Tanne D; Young LH; Kernan WN;
Am Heart J; 2014 Dec; 168(6):823-9.e6. PubMed ID: 25458644
[TBL] [Abstract][Full Text] [Related]
5. Effect of pioglitazone on vascular events in post-stroke cognitive impairment: Post hoc analysis of the IRIS trial.
Schmidt K; Power MC; Ciarleglio A; Nadareishvili Z
Int J Stroke; 2024 Apr; 19(4):414-421. PubMed ID: 38148372
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of a coordinated care intervention to improve risk factor control after stroke or transient ischemic attack in the safety net: Secondary stroke prevention by Uniting Community and Chronic care model teams Early to End Disparities (SUCCEED).
Towfighi A; Cheng EM; Ayala-Rivera M; McCreath H; Sanossian N; Dutta T; Mehta B; Bryg R; Rao N; Song S; Razmara A; Ramirez M; Sivers-Teixeira T; Tran J; Mojarro-Huang E; Montoya A; Corrales M; Martinez B; Willis P; Macias M; Ibrahim N; Wu S; Wacksman J; Haber H; Richards A; Barry F; Hill V; Mittman B; Cunningham W; Liu H; Ganz DA; Factor D; Vickrey BG
BMC Neurol; 2017 Feb; 17(1):24. PubMed ID: 28166784
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a Chronic Care-Based Intervention on Secondary Stroke Prevention Among Vulnerable Stroke Survivors: A Randomized Controlled Trial.
Cheng EM; Cunningham WE; Towfighi A; Sanossian N; Bryg RJ; Anderson TL; Barry F; Douglas SM; Hudson L; Ayala-Rivera M; Guterman JJ; Gross-Schulman S; Beanes S; Jones AS; Liu H; Vickrey BG
Circ Cardiovasc Qual Outcomes; 2018 Jan; 11(1):e003228. PubMed ID: 29321134
[TBL] [Abstract][Full Text] [Related]
8. The NAILED stroke risk factor trial (nurse based age independent intervention to limit evolution of disease after stroke): study protocol for a randomized controlled trial.
Mooe T; Bergström L; Irewall AL; Ogren J
Trials; 2013 Jan; 14():5. PubMed ID: 23289919
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated With Participation in the Chronic Disease Self-Management Program: Findings From the SUCCEED Trial.
Lin AM; Vickrey BG; Barry F; Lee ML; Ayala-Rivera M; Cheng E; Montoya AV; Mojarro-Huang E; Gomez P; Castro M; Corrales M; Sivers-Teixeira T; Tran JL; Johnson R; Ediss C; Shaby B; Willis P; Sanossian N; Mehta B; Dutta T; Razmara A; Bryg R; Song S; Towfighi A
Stroke; 2020 Oct; 51(10):2910-2917. PubMed ID: 32912091
[TBL] [Abstract][Full Text] [Related]
10. In praise of pioglitazone: An economically efficacious therapy for type 2 diabetes and other manifestations of the metabolic syndrome.
Bell DSH; Jerkins T
Diabetes Obes Metab; 2023 Nov; 25(11):3093-3102. PubMed ID: 37534526
[TBL] [Abstract][Full Text] [Related]
11. Periodontal Disease Treatment After Stroke or Transient Ischemic Attack: The PREMIERS Study, a Randomized Clinical Trial.
Sen S; Curtis J; Hicklin D; Nichols C; Glover S; Merchant AT; Hardin JW; Logue M; Meyer J; Mason E; Huang DY; Susin C; Moss K; Beck J
Stroke; 2023 Sep; 54(9):2214-2222. PubMed ID: 37548008
[TBL] [Abstract][Full Text] [Related]
12. PPARγ activation by pioglitazone does not suppress cravings for alcohol, and is associated with a risk of myopathy in treatment seeking alcohol dependent patients: a randomized controlled proof of principle study.
Schwandt ML; Diazgranados N; Umhau JC; Kwako LE; George DT; Heilig M
Psychopharmacology (Berl); 2020 Aug; 237(8):2367-2380. PubMed ID: 32445052
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone Use and Reduced Risk of Dementia in Patients With Diabetes Mellitus With a History of Ischemic Stroke.
Ha J; Choi DW; Kim KJ; Kim KY; Nam CM; Kim E
Neurology; 2023 Apr; 100(17):e1799-e1811. PubMed ID: 36792375
[TBL] [Abstract][Full Text] [Related]
14. Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke.
Zhou Q; Yan H; Jin A; Meng X; Lin J; Li H; Wang Y; Pan Y
Diabetol Metab Syndr; 2023 Dec; 15(1):246. PubMed ID: 38041145
[TBL] [Abstract][Full Text] [Related]
15. Stroke and Transient Ischemic Attack.
Banyas P; Jadhav A
Prim Care; 2024 Jun; 51(2):283-297. PubMed ID: 38692775
[TBL] [Abstract][Full Text] [Related]
16. Post-stroke cognitive impairment and the risk of stroke recurrence and death in patients with insulin resistance.
Schmidt K; Power MC; Ciarleglio A; Nadareishvili Z;
J Stroke Cerebrovasc Dis; 2022 Oct; 31(10):106744. PubMed ID: 36037680
[TBL] [Abstract][Full Text] [Related]
17. Effect and efficacy of lifestyle interventions as secondary prevention.
Liljehult J; Christensen T; Molsted S; Overgaard D; Mesot Liljehult M; Møller T
Acta Neurol Scand; 2020 Oct; 142(4):299-313. PubMed ID: 32620044
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled pilot trial of anakinra and pioglitazone for protein metabolism in patients on maintenance haemodialysis.
Ertuglu LA; Deger SM; Alsouqi A; Hung A; Gamboa J; Mambungu C; Sha F; Siew E; Abumrad NN; Ikizler TA
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):401-411. PubMed ID: 38178557
[TBL] [Abstract][Full Text] [Related]
19. Secondary stroke: new horizons in prevention.
Phillips RA
Clin Cardiol; 2004 May; 27(5 Suppl 2):II1-3. PubMed ID: 15188930
[No Abstract] [Full Text] [Related]
20. A Possible Role for Pioglitazone in the Management of Depressive Symptoms in Metabolic Syndrome Patients (EPICAMP Study): A Double Blind, Randomized Clinical Trial.
Roohafza H; Shokouh P; Sadeghi M; Alikhassy Z; Sarrafzadegan N
Int Sch Res Notices; 2014; 2014():697617. PubMed ID: 27433505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
